Ceapro Inc. (CVE:CZO – Get Free Report) traded down 11.8% during trading on Thursday . The company traded as low as C$0.23 and last traded at C$0.23. 5,850 shares changed hands during trading, a decline of 88% from the average session volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Stock Performance
The business’s fifty day moving average is C$0.22 and its two-hundred day moving average is C$0.23. The stock has a market capitalization of C$17.62 million, a PE ratio of -3.75 and a beta of 1.38. The company has a quick ratio of 18.88, a current ratio of 8.54 and a debt-to-equity ratio of 8.07.
Ceapro Company Profile
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Featured Stories
- Five stocks we like better than Ceapro
- Business Services Stocks Investing
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
